Journal of Adolescent Health
Volume 43, Issue 2 , Pages 115-124 , August 2008

Body Shape and Size and Insulin Resistance as Early Clinical Predictors of Hyperandrogenic Anovulation in Ethnic Minority Adolescent Girls

  • Jessica Rieder, M.D., M.S.

      Affiliations

    • Department of Pediatrics, Division of Adolescent Medicine, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York
    • Corresponding Author InformationAddress correspondence to: Jessica Rieder, M.D., M.S., Department of Pediatrics, Division of Adolescent Medicine, Children's Hospital at Montefiore, 111 East 210th Street, Bronx, NY, 10467.
    • ,
  • Nanette Santoro, M.D.

      Affiliations

    • Dpartment of Obstetrics, Gynecology and Women's Health, Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Hillel W. Cohen, M.P.H., Dr.PH.

      Affiliations

    • Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Paul Marantz, M.D., M.P.H.

      Affiliations

    • Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, New York
    • Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Susan M. Coupey, M.D.

      Affiliations

    • Department of Pediatrics, Division of Adolescent Medicine, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York

Received 29 March 2007 ,Accepted 12 February 2008.

References 

  1. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In:  Dunaif A,  Givens JR,  Haseltine F editor. Polycystic Ovary Syndrome. Boston: Blackwell Scientific; 1992;p. 377–384
  2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25
  3. Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab. 2005;90(8):4836–4845
  4. Dunaif A, Sorbara L, Delson R, et al. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 1993;42(10):1462–1468
  5. World Health Organization Task Force on Adolescent Reproductive Health. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls II (Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health). J Adolesc Health Care. 1986;7(4):236–244
  6. Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12(1 Pt 2):77–126
  7. Wentz AC. Amenorrhea: evaluation and treatment. In:  Jones HW,  Wentz AC,  Burnett LS editor. Novak's Textbook of Gynecology. 11th ed.. Baltimore, MD: Williams and Wilkins; 1988;p. 351
  8. Flegal KM, Ogden CL, Wei R, et al. Prevalence of overweight in US children: comparison of US growth charts from the Centers for Disease Control and Prevention with other reference values for body mass index. Am J Clin Nutr. 2001;73(6):1086–1093
  9. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109(1):45–60
  10. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–1555
  11. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101(3 Pt 2):497–504
  12. In:  Lohman TG,  Roche AF,  Martorell R editor. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetic Books; 1988;p. 44–46Abridged edition
  13. Hatch R Rosenfeld R, Kim MH, et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140:815
  14. Wishart JM. An open study of triphasil and diane 50 in the treatment of acne. Australas J Dermatol. 1991;32:51–54
  15. Redmond GP OW, Lippman JS, et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol. 1997;89(4):615–622
  16. Verkauf BS, Von Thron J, O'Brien WF. Clitoral size in normal women. Obstet Gynecol. 1992;80(1):41–44
  17. Santoro N, Banwell T, Tortoriello D, et al. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998;178:732–741
  18. Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab. 2003;88:5502–5509
  19. Mushayandebvu T, Castracance VD, Gimpel T, et al. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril. 1996;65:721–722
  20. Klein RS, Lo Y, Santoro N, et al. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis. 2005;41:1794–1803
  21. Sotsky MJ, Shilo S, Shamoon H. Regulation of counterregulatory hormone secretion in man during hypoglycemia and exercise. J Clin Endocrinol Metab. 1989;68:9–12
  22. Korhonen S, Hippelainen M, Vanhala M, et al. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril. 2003;79(6):1327–1334
  23. McCartney CR, Prendergast KA, Chhabra S, et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab. 2006;91:1714–1722
  24. Nestler JE, Clone J, Blackard WG. The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Am J Obstet Gynecol. 1989;161(5):1095–1097
  25. Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes. 1989;38:1165–1174
  26. Sozen I, Arici A. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstet Gynecol Surv. 2000;55(5):321–328
  27. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91:393–395
  28. Dunaif A, Graf M, Mandeli J, et al. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987;65(3):499–507
  29. Barbieri RL, Makris A, Randall RW, et al. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62(5):904–910
  30. Nestler JE, Jakubowicz DJ, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–2005
  31. Chang RJ, Nakamura RM, Judd HL, et al. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57(2):356–359
  32. Morales AJ, Laughlin GA, Butzow T, et al. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 1996;81(8):2854–2864
  33. Wang C, Catlin DH, Demers LM, et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2004;89(2):534–543
  34. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672
  35. Cibula D, Hill M, Starka L. The best correlation of the new index of hyperandrogensim with the grade of increased body hair. Eur J Endocrinol. 2000;143:405–408
  36. Imani B, Eijkemans MJ, de Jong FH, et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 2000;85(2):676–682
  37. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52(5):1210–1214
  38. Hirschler V, Aranda C, Oneto A, et al. Is acanthosis nigricans a marker of insulin resistance in obese children?. Diabetes Care. 2002;25(12):2353

 Conflict of Interest: J.R., P.M., H.W.C., and S.M.C. have nothing to declare. N.S. consults for Ferring, Wyeth and Pfizer and received lecture fees from Berlex, Wyeth, Serono and Pfizer.

PII: S1054-139X(08)00121-3

doi: 10.1016/j.jadohealth.2008.02.003

Journal of Adolescent Health
Volume 43, Issue 2 , Pages 115-124 , August 2008

Article Tools

* Image Usage & Resolution